These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 25511778)
61. Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity? Atanasov AG; Odermatt A Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):125-40. PubMed ID: 17584152 [TBL] [Abstract][Full Text] [Related]
62. Impaired negative feedback and death following acute stress in glucocorticoid receptor knockout Xenopus tropicalis tadpoles. Paul B; Sterner ZR; Bhawal R; Anderson ET; Zhang S; Buchholz DR Gen Comp Endocrinol; 2022 Sep; 326():114072. PubMed ID: 35697317 [TBL] [Abstract][Full Text] [Related]
63. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. Speirs HJ; Seckl JR; Brown RW J Endocrinol; 2004 Apr; 181(1):105-16. PubMed ID: 15072571 [TBL] [Abstract][Full Text] [Related]
65. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Vandevyver S; Dejager L; Tuckermann J; Libert C Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835 [TBL] [Abstract][Full Text] [Related]
66. A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling. Glantschnig C; Koenen M; Gil-Lozano M; Karbiener M; Pickrahn I; Williams-Dautovich J; Patel R; Cummins CL; Giroud M; Hartleben G; Vogl E; Blüher M; Tuckermann J; Uhlenhaut H; Herzig S; Scheideler M FASEB J; 2019 May; 33(5):5924-5941. PubMed ID: 30742779 [TBL] [Abstract][Full Text] [Related]
67. 21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action. Pecci A; Alvarez LD; Presman DM; Burton G Mini Rev Med Chem; 2018 Feb; 18(5):428-438. PubMed ID: 26776223 [TBL] [Abstract][Full Text] [Related]
76. The zebrafish as an in vivo model system for glucocorticoid resistance. Schoonheim PJ; Chatzopoulou A; Schaaf MJ Steroids; 2010 Dec; 75(12):918-25. PubMed ID: 20493895 [TBL] [Abstract][Full Text] [Related]
77. Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance. Odermatt A; Gumy C; Atanasov AG; Dzyakanchuk AA J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):222-31. PubMed ID: 17045799 [TBL] [Abstract][Full Text] [Related]
78. Tissue glucocorticoid resistance/hypersensitivity syndromes. Kino T; De Martino MU; Charmandari E; Mirani M; Chrousos GP J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):457-67. PubMed ID: 12943736 [TBL] [Abstract][Full Text] [Related]
79. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues. Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579 [TBL] [Abstract][Full Text] [Related]
80. Tissue-specific expression of 11β-HSD and its effects on plasma corticosterone during the stress response. Pérez JH; Swanson RE; Lau HJ; Cheah J; Bishop VR; Snell KRS; Reid AMA; Meddle SL; Wingfield JC; Krause JS J Exp Biol; 2020 Jan; 223(Pt 1):. PubMed ID: 31796607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]